Strong Revenue Growth
Waystar delivered Q3 revenue of $240 million, representing a 22% year-over-year increase, an acceleration from the 20% growth in Q2 2024.
Sustainable Growth Metrics
Net revenue retention was consistent at 109%, and the number of clients generating more than $100,000 in trailing 12-month revenue grew to 1,173, an increase of 14% year-over-year.
Adjusted EBITDA Growth
Adjusted EBITDA reached $97 million, reflecting a 19% year-over-year increase and a 40% adjusted EBITDA margin.
Debt Reduction Success
Waystar successfully lowered its net leverage ratio to 3x, compared to 3.7x at the end of Q2 2024, with net debt reduced by over $1 billion since the beginning of the year.
Platform Innovation and AI
Waystar is actively working on over a dozen generative AI use cases, with plans to begin launching in 2025.
Client and Employee Recognition
Waystar received several awards, including the Gold Stevie Award for Company of the Year in Healthcare and recognition as a great place to work by several organizations.